nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—OPRD1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0451	0.0507	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0395	0.0444	CbGpPWpGaD
Hydromorphone—Naltrexone—ABCB1—adrenal gland cancer	0.0383	0.349	CrCbGaD
Hydromorphone—OPRM1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0334	0.0375	CbGpPWpGaD
Hydromorphone—Naloxone—ABCB1—adrenal gland cancer	0.028	0.255	CrCbGaD
Hydromorphone—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0267	0.03	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0241	0.0271	CbGpPWpGaD
Hydromorphone—Morphine—ABCB1—adrenal gland cancer	0.0236	0.215	CrCbGaD
Hydromorphone—OPRK1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0211	0.0237	CbGpPWpGaD
Hydromorphone—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0204	0.0229	CbGpPWpGaD
Hydromorphone—Dextromethorphan—ABCB1—adrenal gland cancer	0.0198	0.181	CrCbGaD
Hydromorphone—OPRM1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0178	0.02	CbGpPWpGaD
Hydromorphone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.0176	0.0198	CbGpPWpGaD
Hydromorphone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0175	0.0196	CbGpPWpGaD
Hydromorphone—OPRM1—G-protein activation—POMC—adrenal gland cancer	0.0157	0.0176	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0142	0.016	CbGpPWpGaD
Hydromorphone—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.0138	0.0155	CbGpPWpGaD
Hydromorphone—UGT1A9—PPARA activates gene expression—MED12—adrenal gland cancer	0.0131	0.0147	CbGpPWpGaD
Hydromorphone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.0128	0.0144	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0125	0.014	CbGpPWpGaD
Hydromorphone—OPRM1—Opioid Signalling—PRKACA—adrenal gland cancer	0.0119	0.0134	CbGpPWpGaD
Hydromorphone—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.0114	0.0129	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0108	0.0122	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0105	0.0118	CbGpPWpGaD
Hydromorphone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.00957	0.0108	CbGpPWpGaD
Hydromorphone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00955	0.0107	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0095	0.0107	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CDC42—adrenal gland cancer	0.00929	0.0104	CbGpPWpGaD
Hydromorphone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.00882	0.0099	CbGpPWpGaD
Hydromorphone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00873	0.00981	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00852	0.00957	CbGpPWpGaD
Hydromorphone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00832	0.00934	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00803	0.00902	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0076	0.00853	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00747	0.0084	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00666	0.00748	CbGpPWpGaD
Hydromorphone—OPRM1—Opioid Signalling—POMC—adrenal gland cancer	0.0065	0.0073	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00649	0.00729	CbGpPWpGaD
Hydromorphone—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00636	0.00714	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00632	0.0071	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00612	0.00688	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00591	0.00664	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00578	0.0065	CbGpPWpGaD
Hydromorphone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00576	0.00647	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00569	0.00639	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00563	0.00632	CbGpPWpGaD
Hydromorphone—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00559	0.00628	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00556	0.00625	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00556	0.00624	CbGpPWpGaD
Hydromorphone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00548	0.00616	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00537	0.00603	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00507	0.0057	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00488	0.00548	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00487	0.00547	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00481	0.0054	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00454	0.0051	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00444	0.00498	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00429	0.00482	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00412	0.00463	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00412	0.00463	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00405	0.00454	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00389	0.00437	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00374	0.0042	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00367	0.00412	CbGpPWpGaD
Hydromorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00365	0.00411	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—POMC—adrenal gland cancer	0.00364	0.00409	CbGpPWpGaD
Hydromorphone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00362	0.00407	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00351	0.00394	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00337	0.00378	CbGpPWpGaD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00334	0.00376	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00333	0.00374	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00329	0.00369	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00328	0.00369	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00328	0.00369	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00327	0.00367	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—SDHB—adrenal gland cancer	0.00325	0.00366	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00322	0.00361	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00305	0.00343	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00298	0.00334	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00297	0.00333	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.00297	0.00333	CbGpPWpGaD
Hydromorphone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00296	0.00333	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00295	0.00331	CbGpPWpGaD
Hydromorphone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00294	0.0033	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00292	0.00328	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00288	0.00324	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00287	0.00322	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00287	0.00322	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00286	0.00322	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00277	0.00312	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00272	0.00305	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00268	0.00301	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.00265	0.00298	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00261	0.00293	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	0.0026	0.00292	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00256	0.00288	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00252	0.00283	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00249	0.0028	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00247	0.00277	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00243	0.00273	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00242	0.00272	CbGpPWpGaD
Hydromorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00239	0.00268	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.00227	0.00255	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00226	0.00254	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0022	0.00248	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.0022	0.00247	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00213	0.00239	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00213	0.00239	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—SDHD—adrenal gland cancer	0.0021	0.00236	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—RRM1—adrenal gland cancer	0.0021	0.00236	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00209	0.00235	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00199	0.00224	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	0.00199	0.00223	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00197	0.00221	CbGpPWpGaD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00194	0.00218	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0019	0.00214	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00187	0.0021	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00181	0.00203	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.0018	0.00202	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.00175	0.00197	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00175	0.00196	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00173	0.00194	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00173	0.00194	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.00171	0.00192	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.00171	0.00192	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00168	0.00189	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00167	0.00187	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.00165	0.00185	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00158	0.00178	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00158	0.00177	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00158	0.00177	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00157	0.00177	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—MED12—adrenal gland cancer	0.00156	0.00176	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00156	0.00175	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	0.00154	0.00173	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00151	0.0017	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.0015	0.00169	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00147	0.00166	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00146	0.00164	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	0.00145	0.00162	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00141	0.00158	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00141	0.00158	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.0014	0.00157	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.00139	0.00157	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00134	0.0015	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00133	0.0015	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.0013	0.00146	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00128	0.00144	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00128	0.00144	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—MED12—adrenal gland cancer	0.00127	0.00143	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00126	0.00141	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00122	0.00137	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.00116	0.00131	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PRKACA—adrenal gland cancer	0.00114	0.00128	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00114	0.00128	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00112	0.00126	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00111	0.00125	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	0.0011	0.00124	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.0011	0.00123	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.00107	0.0012	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.00103	0.00116	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00103	0.00116	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.00102	0.00115	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	0.00102	0.00115	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000995	0.00112	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000949	0.00107	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	0.000936	0.00105	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000933	0.00105	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PRKACA—adrenal gland cancer	0.00093	0.00104	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GNAS—adrenal gland cancer	0.000925	0.00104	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00092	0.00103	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000909	0.00102	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ABCB1—adrenal gland cancer	0.000907	0.00102	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000907	0.00102	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000907	0.00102	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	0.000902	0.00101	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000899	0.00101	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000899	0.00101	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	0.000895	0.001	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000872	0.00098	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000862	0.000968	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000856	0.000962	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000791	0.000889	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000763	0.000857	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000756	0.000849	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GNAS—adrenal gland cancer	0.000754	0.000847	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	0.000751	0.000844	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000745	0.000837	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ABCB1—adrenal gland cancer	0.00074	0.000831	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000737	0.000828	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000687	0.000772	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000678	0.000762	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000676	0.000759	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.00067	0.000753	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000657	0.000739	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	0.000653	0.000734	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000635	0.000713	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—POMC—adrenal gland cancer	0.000623	0.000699	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	0.000602	0.000677	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000599	0.000673	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	0.000595	0.000668	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000593	0.000666	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000593	0.000666	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000576	0.000648	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000552	0.00062	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000509	0.000572	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—POMC—adrenal gland cancer	0.000507	0.00057	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000503	0.000565	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—adrenal gland cancer	0.000497	0.000558	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000493	0.000554	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00049	0.000551	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000489	0.000549	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000487	0.000547	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000478	0.000537	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000442	0.000496	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00043	0.000483	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—adrenal gland cancer	0.000405	0.000455	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.0004	0.000449	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000396	0.000445	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000392	0.000441	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000389	0.000437	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000388	0.000436	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000363	0.000408	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	0.000341	0.000383	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000326	0.000366	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000322	0.000362	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000288	0.000323	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	0.000286	0.000321	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000269	0.000302	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000267	0.0003	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000261	0.000294	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000256	0.000288	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000242	0.000271	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000215	0.000241	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000213	0.000239	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000176	0.000198	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.00014	0.000158	CbGpPWpGaD
